Swartz Allison sold $45K of PGNY
Swartz Allison (EVP, GC) sold 1,798 shares of Progyny, Inc. (PGNY) at an average of $25.04 ($25.02–$25.08) across 2 trades over 2026-06-03 to 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The modest sale is unlikely to materially move the stock but may be noted by short‑term traders.
Market read
A routine insider sale with limited size; low trading relevance.
What to watch
Potential upcoming regulatory or legal matters not disclosed that prompted the insider to reduce exposure.
Background
SEC Form 4 filing discloses an insider's open‑market sale under a pre‑arranged 10b5‑1 plan.
Ticker impact
EVP & General Counsel Swartz Allison sold 1,798 shares (~$45K) via a 10b5‑1 plan, reducing holdings to 82,378 shares.
likely modest downward pressure as the market prices in the insider sale
A small open‑market sale by a senior officer can prompt short‑term selling pressure, though the amount is modest relative to float.
Market effects
Minimal; the transaction does not affect the broader benefits‑technology sector.
None; the filing is U.S. specific and limited to Progyny.
Low; no cross‑border or macro implications.
Counterpoint
The sale could be unrelated to company fundamentals and merely a personal liquidity move.
Key entities
- CompanyProgyny, Inc.
U.S. benefits‑technology firm (ticker PGNY).
- ExecutiveSwartz Allison
Executive Vice President & General Counsel of Progyny.
